increased hematocrit_Vhl<tm1Jae>/Vhl<tm1Jae>,Tg(Alb-cre)21Mgn/0

http://metadb.riken.jp/0002608I129S4SvJaeC57BL6DBAVhltm1JaeVhltm1JaeTgAlbcre21Mgn0Vhltm1JaeTgAlbcre21Mgn

increased hematocrit_Vhl<tm1Jae>/Vhl<tm1Jae>,Tg(Alb-cre)21Mgn/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion 21, Mark A Magnuson
  http://metadb.riken.jp/db/mgi_rdf/MGI:2176226
• von Hippel-Lindau tumor suppressor
  http://metadb.riken.jp/db/mgi_rdf/MGI:103223

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Vhl<tm1Jae>/Vhl<tm1Jae>,Tg(Alb-cre)21Mgn/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Vhl<tm1Jae>|Tg(Alb-cre)21Mgn

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S4/SvJae * C57BL/6 * DBA

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased hematocrit
  http://purl.obolibrary.org/obo/MP_0002608

文献

http://purl.org/net/cito/citesAsAuthority

• William Y. Kim, et.al., Failure to prolyl hydroxylate hypoxia-inducible factor alpha phenocopies VHL inactivation in vivo., The EMBO journal, 2006, 25
  http://rdf.ncbi.nlm.nih.gov/pubmed/16977322